Hyundai Pharmaceutical

현대약품KRX: 004310· Fiscal year 2025· hyundaipharm.co.kr ↗

Average salary
$53.8K
₩71.7M
▲ 9.1% vs 2024
Employees
399
▼ 0.5% vs 2024
Average tenure
9.4 yrs

Estimated take-home of this pay:$3.7K / monthCalculate →

Workplace

Women's pay (men = 100)80
Women among staff21.6%
Contract staff2.8%

Recent official filings

Quick read

  • Average pay is 17% above the median of the companies we track.
  • Average pay rose 9.1% from 2024.
  • Headcount shrank by 2 (0.5%) from 2024.
  • Ranks #41 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 9.1% year over year.
  • Operating margin was 2.2% in 2025.

Last 3 years

Revenue
$135.7M2023$131.9M2024$144.0M2025
Operating income
$5.2M2023$135.8K2024$3.1M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$359.9K
Net profit per employee
$4.7K
Operating margin
2.2%
Net margin
1.3%
ROE
3.1%
Debt-to-equity
98.8%
Equity ratio
50.3%
Payout ratio
31.2%
Dividend per share
$0
Dividend yield (as disclosed)
0.3%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.